ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 135 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,615 | -8.1% | 1,767 | 0.0% | 0.00% | – |
Q2 2023 | $2,845 | -7.5% | 1,767 | +66.5% | 0.00% | – |
Q1 2023 | $3,077 | -72.0% | 1,061 | -68.3% | 0.00% | – |
Q4 2022 | $10,985 | -62.1% | 3,349 | -56.3% | 0.00% | – |
Q3 2022 | $29,000 | +2800.0% | 7,664 | +6394.9% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 118 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -66.7% | 118 | -43.5% | 0.00% | – |
Q4 2021 | $3,000 | -25.0% | 209 | 0.0% | 0.00% | – |
Q3 2021 | $4,000 | +33.3% | 209 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 209 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | -25.0% | 209 | 0.0% | 0.00% | – |
Q4 2020 | $4,000 | 0.0% | 209 | -23.7% | 0.00% | – |
Q3 2020 | $4,000 | +33.3% | 274 | +31.1% | 0.00% | – |
Q2 2020 | $3,000 | +50.0% | 209 | -11.1% | 0.00% | – |
Q1 2020 | $2,000 | -60.0% | 235 | -27.9% | 0.00% | – |
Q4 2019 | $5,000 | 0.0% | 326 | -4.7% | 0.00% | – |
Q3 2019 | $5,000 | – | 342 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antipodean Advisors LLC | 800,000 | $11,656,000 | 5.38% |
Consonance Capital Management LP | 5,238,218 | $76,321,000 | 4.57% |
BRIDGER MANAGEMENT, LLC | 1,785,784 | $26,019,000 | 2.41% |
Trellus Management Company, LLC | 150,000 | $2,186,000 | 2.37% |
MAVERICK CAPITAL LTD | 6,754,102 | $98,407,000 | 2.07% |
Redmile Group, LLC | 6,843,370 | $99,708,000 | 1.84% |
Baupost Group | 9,922,030 | $144,564,000 | 1.80% |
Camber Capital Management LP | 1,400,000 | $20,398,000 | 1.17% |
Pinz Capital Management, LP | 161,100 | $2,347,000 | 1.08% |
Artal Group S.A. | 2,500,000 | $36,425,000 | 1.02% |